2021
DOI: 10.1182/bloodadvances.2020002442
|View full text |Cite
|
Sign up to set email alerts
|

Neutrophil specific granule and NETosis defects in gray platelet syndrome

Abstract: Gray platelet syndrome (GPS) is an autosomal recessive bleeding disorder characterized by a lack of α-granules in platelets and progressive myelofibrosis. Rare loss-of-function variants in neurobeachin-like 2 (NBEAL2), a member of the family of beige and Chédiak-Higashi (BEACH) genes, are causal of GPS. It is suggested that BEACH domain containing proteins are involved in fusion, fission, and trafficking of vesicles and granules. Studies in knockout mice suggest that NBEAL2 may control the formation and retent… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
34
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 21 publications
(35 citation statements)
references
References 52 publications
1
34
0
Order By: Relevance
“…thrombin, protease-activated receptor 1 (PAR1)-and PAR4-AP (activating peptide) was a consistent finding in several studies 1,22,39 and seems to be a common defect in GPS patients, which may be paralleled by a reduction in PAR1 and PAR4 expression in megakaryocytes and platelets. 22,39 Although the total P-selectin pool may be normal or mildly reduced in GPS platelets, 1 P-selectin was found to be constitutively expressed on the platelet surface in one study, 18 whereas upregulation of P-selectin exposure in response to agonists, was markedly impaired, both in this work 18 and in a separate study. 39 Mice lacking NBEAL2 display platelet functional abnormalities, [30][31][32] delayed arterial thrombus formation 30 and protection from thrombo-inflammatory brain injury following focal cerebral ischemia.…”
Section: Dovepressmentioning
confidence: 49%
See 3 more Smart Citations
“…thrombin, protease-activated receptor 1 (PAR1)-and PAR4-AP (activating peptide) was a consistent finding in several studies 1,22,39 and seems to be a common defect in GPS patients, which may be paralleled by a reduction in PAR1 and PAR4 expression in megakaryocytes and platelets. 22,39 Although the total P-selectin pool may be normal or mildly reduced in GPS platelets, 1 P-selectin was found to be constitutively expressed on the platelet surface in one study, 18 whereas upregulation of P-selectin exposure in response to agonists, was markedly impaired, both in this work 18 and in a separate study. 39 Mice lacking NBEAL2 display platelet functional abnormalities, [30][31][32] delayed arterial thrombus formation 30 and protection from thrombo-inflammatory brain injury following focal cerebral ischemia.…”
Section: Dovepressmentioning
confidence: 49%
“…Interestingly, however, neutrophil extracellular trap (NET) formation was blunted or substantially reduced in response to classic NET inducers, such as PMA, urate crystals and Candida albicans, which engage different NET-triggering pathways. 18 Considering that upstream steps of NET formation, such as ROS production and myeloperoxidase and elastase reactivity were not altered in GPS neutrophils, this finding suggests that, in addition to azurophilic granules, specific granules may play a previously unrecognized role in NET formation. This granule subset may be particularly important in the late phases of NETosis, as reflected by defective membrane rupture and chromatin web release, whereas initial steps such as chromatin decondensation and cell rounding proceeded normally.…”
Section: Innate Immune Cell Dysfunctionmentioning
confidence: 81%
See 2 more Smart Citations
“…This is a progressive syndrome, such that usually evolves towards severe thrombocytopenia during adolescence and adulthood, accompanied by a gradual degree of myelofibrosis and, in some cases, splenomegaly. Very recently, these patients have been reported to exhibit leukopenia, predisposition to autoimmune diseases, defective NETosis and to developing autoantibodies [ 51 , 53 , 158 , 159 ].…”
Section: Inherited Platelet Disorders Of Particular Clinical Relevancementioning
confidence: 99%